Abstract | BACKGROUND AND PURPOSE: Hyperbaric oxygen (HBO) preconditioning (PC) allows brain protection against transient global ischemia. In the present study, we hypothesize that the mechanism of HBO-PC involves the induction of cyclooxygenase-2 (COX-2) in cerebral tissues before ischemia, which leads to a suppression of COX-2 and its downstream targets after global ischemic insult. METHODS: One hundred twenty-nine male Sprague Dawley rats ( body weight 280-300 grams) were allocated to the naive control group and the sham operation group, and 3 groups of animals were subjected to 15-minute 4-vessel occlusion: untreated, preconditioned with HBO 2.5 atmospheres absolutes for 1 hour daily for 5 days, preconditioned as mentioned and administered with COX-2 inhibitor NS-398 (1 mg/kg body weight intraperitoneal) before each preconditioning session, and normal rats preconditioned with HBO without ischemia. The mortality, the incidence of seizures, and T-maze scores were recorded. The quantitative cell count in Nissl stain and TUNEL was conducted on day 7 after ischemia. The brain expression of COX-2 was analyzed with Western blotting and immunofluorescence staining. RESULTS: HBO-PC increased the number of surviving neurons in the Cornu Ammonis area 1, which was associated with the reduced COX-2 expression in the hippocampus and in the cerebral cortex at 1 and 3 days after ischemia. HBO-PC improved functional performance and tended to decrease mortality and the frequency of seizures. These beneficial effects of HBO-PC were abolished by the COX-2 selective inhibitor NS-398. CONCLUSIONS: HBO-PC reduced COX-2 expression and provided brain protection after global ischemia. Administration of COX-2 inhibitor with HBO before ischemia abolished preconditioning effect, thereby implicating COX-2 as a mediator of HBO-PC in the ischemic brain.
|
Authors | Oumei Cheng, Robert P Ostrowski, Bihua Wu, Wenwu Liu, Chunhua Chen, John H Zhang |
Journal | Stroke
(Stroke)
Vol. 42
Issue 2
Pg. 484-90
(Feb 2011)
ISSN: 1524-4628 [Electronic] United States |
PMID | 21164135
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Cyclooxygenase 2 Inhibitors
- Neuroprotective Agents
- Cyclooxygenase 2
|
Topics |
- Animals
- Brain
(blood supply, drug effects, enzymology)
- Cyclooxygenase 2
(physiology)
- Cyclooxygenase 2 Inhibitors
(pharmacology)
- Disease Models, Animal
- Hyperbaric Oxygenation
(methods)
- Ischemic Attack, Transient
(enzymology, metabolism, therapy)
- Ischemic Preconditioning
(methods)
- Male
- Neuroprotective Agents
(administration & dosage, pharmacology)
- Rats
- Rats, Sprague-Dawley
|